Manhattan Institute Preparing FDA "Critical Path" Recommendations
This article was originally published in The Pink Sheet Daily
Executive Summary
The task force includes three ex-FDAers: former Associate Commissioner for External Relations Pitts, former Office of Cellular, Tissues & Gene Therapies Acting Director Noguchi and former Director of Medical Policy Development Gottlieb. The group hopes to reform FDA's drug approval and safety monitoring procedures.